Behavior of Infants Fed Formula Supplemented With Prebiotics

June 16, 2017 updated by: Abbott Nutrition

Behavior of Infants Fed a Partially Hydrolyzed Formula Supplemented With Prebiotics

To observe the effects of partially hydrolyzed formula supplemented with oligosaccharides on symptoms of formula intolerance in healthy term infants.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Dothan, Alabama, United States, 36305
        • Southeastern Pediatric Associates
    • Florida
      • Pensacola, Florida, United States, 32503
        • Pensacola Research Consultants, Inc
      • Saint Petersburg, Florida, United States, 33710
        • SCORE Physician Alliance, LLC
    • Indiana
      • Evansville, Indiana, United States, 47713
        • Deaconess Clinic, Inc.
    • Kentucky
      • Bardstown, Kentucky, United States, 40004
        • Kentucky Pediatric/Adult Research
    • Nebraska
      • Lincoln, Nebraska, United States, 68510
        • Women's Clinic of Lincoln, PC
    • Ohio
      • Grove City, Ohio, United States, 43123
        • Aventiv Research
    • South Carolina
      • Charleston, South Carolina, United States, 29414
        • Coastal Pediatric Research
    • Tennessee
      • Bristol, Tennessee, United States, 37620
        • Holston Medical Group
      • Kingsport, Tennessee, United States, 37660
        • Holston Medical Group
    • Texas
      • San Antonio, Texas, United States, 78229
        • Southwest Children's Research Associates, P.A.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 week to 1 month (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject is judged to be in good health.
  • Subject is a singleton from a full-term birth with a gestational age of 37 - 42 weeks.
  • Subject's birth weight was ≥ 2490 g (~5 lbs. 8 oz.).
  • Infant was identified by parents as very fussy or extremely fussy.
  • Infant is exclusively formula-fed at time of study entry. Parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study.
  • Parent(s) confirm their intention not to administer vitamin or mineral supplements, solid foods or juices to their infant from enrollment through the duration of the study.

Exclusion Criteria:

  • An adverse maternal, fetal or subject medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development.
  • Subject is taking and plans to continue medications, home remedies (such as juice for constipation), herbal preparations or rehydration fluids that might affect GI tolerance.
  • Subject participates in another study that has not been approved as a concomitant study.
  • Subject has been fed any formula containing human milk oligosaccharides prior to study enrollment.
  • Subject has been treated with oral antibiotics within 7 days prior to study enrollment.
  • Mother intends to use a combination of breast and formula feeding.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Infant formula supplemented with prebiotics
infant formula powder, feed ad libitum
Sole source nutrition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fussiness
Time Frame: Change from baseline (3 days prior to study day 1) to within 1 day of initiation of study feeding
Parent questionnaires
Change from baseline (3 days prior to study day 1) to within 1 day of initiation of study feeding

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fussiness
Time Frame: Baseline to Day 29
Parent Questionnaires
Baseline to Day 29
Hours of Daily Crying
Time Frame: Baseline to Day 29
Parent Questionnaires
Baseline to Day 29
Gastrointestinal Tolerance
Time Frame: Baseline to Day 29
Parent Questionnaires
Baseline to Day 29
Stool Pattern
Time Frame: Baseline to Day 29
Parent Questionnaires
Baseline to Day 29

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Marlene Borschel, PhD, RD, LD, Abbott Nutrition

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 1, 2016

Primary Completion (ACTUAL)

May 2, 2017

Study Completion (ACTUAL)

May 2, 2017

Study Registration Dates

First Submitted

April 28, 2016

First Submitted That Met QC Criteria

April 29, 2016

First Posted (ESTIMATE)

May 2, 2016

Study Record Updates

Last Update Posted (ACTUAL)

June 19, 2017

Last Update Submitted That Met QC Criteria

June 16, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • AL20

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrointestinal Tolerance

Clinical Trials on Infant formula supplemented with prebiotics

3
Subscribe